BDBM193745 1-(3-((2-Hydroxy-6-oxocyclohex-1-en-1-yl)diazenyl)phenyl)-5-phenyl-N3,N4-bis(5-sulfamoyl-1,3,4-thiadiazol-2-yl)-1H-pyrazole-3,4-dicarboxamide (13)

SMILES: [#7]S(=O)(=O)c1nnc(-[#7]-[#6](=O)-c2nn(c(c2-[#6](=O)-[#7]-c2nnc(s2)S([#7])(=O)=O)-c2ccccc2)-c2cccc(-[#7]\[#7]=[#6]-3/[#6](=O)-[#6]-[#6]-[#6]-[#6]-3=O)c2)s1

InChI Key: InChIKey=RNXKCPNVYGFQOO-UHFFFAOYSA-N

Data: 2 KI

Find this compound or compounds like it in BindingDB or PDB:

Substructure Similarity at least:  must be >=0.5 Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 2 hits for monomerid = 193745   

Target/Host (Institution)	Ligand	Target/Host Links	Ligand Links	Trg + Lig Links	Ki nM	ΔG° kcal/mole	IC50 nM	Kd nM	EC50/IC50 nM	koff s-1	kon M-1s-1	pH	Temp °C
Carbonic anhydrase 2 (Homo sapiens (Human))	BDBM193745 (1-(3-((2-Hydroxy-6-oxocyclohex-1-en-1-yl)diazenyl)...) Show SMILES [#7]S(=O)(=O)c1nnc(-[#7]-[#6](=O)-c2nn(c(c2-[#6](=O)-[#7]-c2nnc(s2)S([#7])(=O)=O)-c2ccccc2)-c2cccc(-[#7]\[#7]=[#6]-3/[#6](=O)-[#6]-[#6]-[#6]-[#6]-3=O)c2)s1 Show InChI InChI=1S/C27H22N12O8S4/c28-50(44,45)26-36-34-24(48-26)30-22(42)18-20(23(43)31-25-35-37-27(49-25)51(29,46)47)38-39(21(18)13-6-2-1-3-7-13)15-9-4-8-14(12-15)32-33-19-16(40)10-5-11-17(19)41/h1-4,6-9,12,32H,5,10-11H2,(H2,28,44,45)(H2,29,46,47)(H,30,34,42)(H,31,35,43)	PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem Similars	Article PubMed	157	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Dumlupinar University					Assay Description CA activity was measured according to the method described by Verpoorte et al. in inhibition studies, spectrophotometrically [Biochem., 242:4221-4229...				Bioorg Chem 68: 64-71 (2016) Article DOI: 10.1016/j.bioorg.2016.07.006 BindingDB Entry DOI: 10.7270/Q2N29VQC
					More data for this Ligand-Target Pair
Carbonic anhydrase 1 (Homo sapiens (Human))	BDBM193745 (1-(3-((2-Hydroxy-6-oxocyclohex-1-en-1-yl)diazenyl)...) Show SMILES [#7]S(=O)(=O)c1nnc(-[#7]-[#6](=O)-c2nn(c(c2-[#6](=O)-[#7]-c2nnc(s2)S([#7])(=O)=O)-c2ccccc2)-c2cccc(-[#7]\[#7]=[#6]-3/[#6](=O)-[#6]-[#6]-[#6]-[#6]-3=O)c2)s1 Show InChI InChI=1S/C27H22N12O8S4/c28-50(44,45)26-36-34-24(48-26)30-22(42)18-20(23(43)31-25-35-37-27(49-25)51(29,46)47)38-39(21(18)13-6-2-1-3-7-13)15-9-4-8-14(12-15)32-33-19-16(40)10-5-11-17(19)41/h1-4,6-9,12,32H,5,10-11H2,(H2,28,44,45)(H2,29,46,47)(H,30,34,42)(H,31,35,43)	PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem Similars	Article PubMed	508	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Dumlupinar University					Assay Description CA activity was measured according to the method described by Verpoorte et al. in inhibition studies, spectrophotometrically [Biochem., 242:4221-4229...				Bioorg Chem 68: 64-71 (2016) Article DOI: 10.1016/j.bioorg.2016.07.006 BindingDB Entry DOI: 10.7270/Q2N29VQC
					More data for this Ligand-Target Pair